Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors

Marcus A. Lawson, Jennifer M. Parrott, Robert H. McCusker, Robert Dantzer, Keith W. Kelley, Jason O'connor

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Background: Activation of the tryptophan degrading enzyme indoleamine-2,3-dioxygenase 1 (IDO1) is associated with the development of behavioral signs of depression. Systemic immune challenge induces IDO1 in both the periphery and the brain, leading to increased circulating and brain concentrations of kynurenines. However, whether IDO1 activity within the brain is necessary for the manifestation of depression-like behavior of mice following a central immune challenge remains to be elucidated.Methods: We investigated the role of brain IDO1 in mediating depression-like behavior of mice in response to intracerebroventricular injection of saline or lipopolysaccharide (LPS, 10 ng).Results: LPS increased the duration of immobility in the tail suspension test and decreased preference for a sucrose solution. These effects were associated with an activation of central but not peripheral IDO1, as LPS increased brain kynurenine but had no effect on plasma concentrations of kynurenine. Interestingly, genetic deletion or pharmacological inhibition of IDO1, using 1-methyl-tryptophan, abrogated the reduction in sucrose preference induced by intracerebroventricular LPS. 1-Methyl-tryptophan also blocked the LPS-induced increase in duration of immobility during the tail suspension test.Conclusions: These data indicate that activation of brain IDO1 is sufficient to induce depression-like behaviors of mice in response to central LPS.

Original languageEnglish (US)
Article number87
JournalJournal of Neuroinflammation
Volume10
DOIs
StatePublished - Jul 18 2013

Fingerprint

Indoleamine-Pyrrole 2,3,-Dioxygenase
Lipopolysaccharides
Depression
Kynurenine
Brain
Hindlimb Suspension
Sucrose
Tryptophan
Pharmacology
Injections
Enzymes

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Neurology
  • Immunology
  • Neuroscience(all)
  • Medicine(all)

Cite this

Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. / Lawson, Marcus A.; Parrott, Jennifer M.; McCusker, Robert H.; Dantzer, Robert; Kelley, Keith W.; O'connor, Jason.

In: Journal of Neuroinflammation, Vol. 10, 87, 18.07.2013.

Research output: Contribution to journalArticle

Lawson, Marcus A. ; Parrott, Jennifer M. ; McCusker, Robert H. ; Dantzer, Robert ; Kelley, Keith W. ; O'connor, Jason. / Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. In: Journal of Neuroinflammation. 2013 ; Vol. 10.
@article{8298bc338ae84598bd060d20e83bce2c,
title = "Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors",
abstract = "Background: Activation of the tryptophan degrading enzyme indoleamine-2,3-dioxygenase 1 (IDO1) is associated with the development of behavioral signs of depression. Systemic immune challenge induces IDO1 in both the periphery and the brain, leading to increased circulating and brain concentrations of kynurenines. However, whether IDO1 activity within the brain is necessary for the manifestation of depression-like behavior of mice following a central immune challenge remains to be elucidated.Methods: We investigated the role of brain IDO1 in mediating depression-like behavior of mice in response to intracerebroventricular injection of saline or lipopolysaccharide (LPS, 10 ng).Results: LPS increased the duration of immobility in the tail suspension test and decreased preference for a sucrose solution. These effects were associated with an activation of central but not peripheral IDO1, as LPS increased brain kynurenine but had no effect on plasma concentrations of kynurenine. Interestingly, genetic deletion or pharmacological inhibition of IDO1, using 1-methyl-tryptophan, abrogated the reduction in sucrose preference induced by intracerebroventricular LPS. 1-Methyl-tryptophan also blocked the LPS-induced increase in duration of immobility during the tail suspension test.Conclusions: These data indicate that activation of brain IDO1 is sufficient to induce depression-like behaviors of mice in response to central LPS.",
author = "Lawson, {Marcus A.} and Parrott, {Jennifer M.} and McCusker, {Robert H.} and Robert Dantzer and Kelley, {Keith W.} and Jason O'connor",
year = "2013",
month = "7",
day = "18",
doi = "10.1186/1742-2094-10-87",
language = "English (US)",
volume = "10",
journal = "Journal of Neuroinflammation",
issn = "1742-2094",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors

AU - Lawson, Marcus A.

AU - Parrott, Jennifer M.

AU - McCusker, Robert H.

AU - Dantzer, Robert

AU - Kelley, Keith W.

AU - O'connor, Jason

PY - 2013/7/18

Y1 - 2013/7/18

N2 - Background: Activation of the tryptophan degrading enzyme indoleamine-2,3-dioxygenase 1 (IDO1) is associated with the development of behavioral signs of depression. Systemic immune challenge induces IDO1 in both the periphery and the brain, leading to increased circulating and brain concentrations of kynurenines. However, whether IDO1 activity within the brain is necessary for the manifestation of depression-like behavior of mice following a central immune challenge remains to be elucidated.Methods: We investigated the role of brain IDO1 in mediating depression-like behavior of mice in response to intracerebroventricular injection of saline or lipopolysaccharide (LPS, 10 ng).Results: LPS increased the duration of immobility in the tail suspension test and decreased preference for a sucrose solution. These effects were associated with an activation of central but not peripheral IDO1, as LPS increased brain kynurenine but had no effect on plasma concentrations of kynurenine. Interestingly, genetic deletion or pharmacological inhibition of IDO1, using 1-methyl-tryptophan, abrogated the reduction in sucrose preference induced by intracerebroventricular LPS. 1-Methyl-tryptophan also blocked the LPS-induced increase in duration of immobility during the tail suspension test.Conclusions: These data indicate that activation of brain IDO1 is sufficient to induce depression-like behaviors of mice in response to central LPS.

AB - Background: Activation of the tryptophan degrading enzyme indoleamine-2,3-dioxygenase 1 (IDO1) is associated with the development of behavioral signs of depression. Systemic immune challenge induces IDO1 in both the periphery and the brain, leading to increased circulating and brain concentrations of kynurenines. However, whether IDO1 activity within the brain is necessary for the manifestation of depression-like behavior of mice following a central immune challenge remains to be elucidated.Methods: We investigated the role of brain IDO1 in mediating depression-like behavior of mice in response to intracerebroventricular injection of saline or lipopolysaccharide (LPS, 10 ng).Results: LPS increased the duration of immobility in the tail suspension test and decreased preference for a sucrose solution. These effects were associated with an activation of central but not peripheral IDO1, as LPS increased brain kynurenine but had no effect on plasma concentrations of kynurenine. Interestingly, genetic deletion or pharmacological inhibition of IDO1, using 1-methyl-tryptophan, abrogated the reduction in sucrose preference induced by intracerebroventricular LPS. 1-Methyl-tryptophan also blocked the LPS-induced increase in duration of immobility during the tail suspension test.Conclusions: These data indicate that activation of brain IDO1 is sufficient to induce depression-like behaviors of mice in response to central LPS.

UR - http://www.scopus.com/inward/record.url?scp=84880183932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880183932&partnerID=8YFLogxK

U2 - 10.1186/1742-2094-10-87

DO - 10.1186/1742-2094-10-87

M3 - Article

C2 - 23866724

AN - SCOPUS:84880183932

VL - 10

JO - Journal of Neuroinflammation

JF - Journal of Neuroinflammation

SN - 1742-2094

M1 - 87

ER -